MMD could interact with this inflammation pathway, blocking Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B cells (NF-kB) related gene expression and the inflammation-based headache (18). The gene discussed is NFKB1; the disease is multiminicore myopathy.